Abera Surendran

University of Ottawa — Canada

Medicine · Health Sciences

9h-index353citations14works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(7), Virus-based gene therapy research(4), COVID-19 Clinical Research Studies(3), Animal Virus Infections Studies(3), Cancer Research and Treatments(3)

Publications14 total

Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment
Frontiers in Immunology·2023· 12 citedOpen Access
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy
Nature Communications·2022· 46 citedOpen Access
Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer
Molecular Therapy — Oncolytics·2022· 25 citedOpen Access
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection
Molecular Therapy·2021· 23 citedOpen Access
Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Journal of Visualized Experiments·2021
Detection of SARS-CoV-2 Receptor-Binding Domain Antibody using a HiBiT-Based Bioreporter
Journal of Visualized Experiments·2021· 2 cited
A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion
Nanomaterials·2021· 11 citedOpen Access
Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction
International Journal of Molecular Sciences·2021· 32 citedOpen Access
Characterization of Critical Determinants of ACE2-RBD Interaction
2021Open Access
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization
Membranes·2020· 24 citedOpen Access
Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis
Cancers·2020· 25 citedOpen Access
Generating Primary Models of Human Cancer to Aid in the Development of Clinically Relevant Oncolytic Viruses
Methods in molecular biology·2019· 2 cited
Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
EBioMedicine·2018· 147 citedOpen Access
Comparing multi-module connections in membrane chromatography scale-up
Journal of Biotechnology·2015· 4 cited

Frequent Co-authors

Carolina S. Ilkow(13), Taha Azad(10), Joanna Poutou(9), Taylor R. Jamieson(9), Reza Rezaei(9), Ragunath Singaravelu(9), John C. Bell(8), Mathieu J. F. Crupi(7), Jaahnavi Dave(6), Zaid Taha(5), Bradley Austin(5), Jean‐Simon Diallo(5), Stephen Boulton(5), Sarah Tucker(5), Adrian Pelin(4), Nikolas T. Martin(4), Marie-Ève Wedge(3), Christiano Tanese de Souza(3), Julia Petryk(3), Emily E. F. Brown(3)